BELGRADE, Mont., Nov. 22, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has been invited to present at LD MICRO's 4th Annual Conference on December 8, 2011. The conference will be held at the Luxe Hotel in Los Angeles.
Bacterin's chairman and CEO, Guy Cook, is scheduled to present on Thursday, December 8, 2011 at 10:30 a.m. Pacific time, with one-on-one meetings held throughout the day. Management will discuss Bacterin's recent quarterly results, as well as the company's business plan and objectives for the remainder of 2011.
Bacterin reported record revenue of $7.5 million in the third quarter 2011, up 80% year-over-year. For 2012, management expects revenue of $53 million to $56 million.
The LD MICRO Conference brings together 101 presenting companies with more than 150 institutions focused on investing in small and micro cap companies across multiple industries.
About LD MICRO
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor. For more information on the list of presenting companies or to register for the event, please visit www.ldmicro.com or call +1-408-457-1042.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics
|SOURCE Bacterin International Holdings, Inc.|
Copyright©2010 PR Newswire.
All rights reserved